Tekla Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-36,351
| Closed | -$1.82M | – | 151 |
|
|
2016
Q3 | $1.82M | Hold |
36,351
| – | – | 0.07% | 121 |
|
|
2016
Q2 | $1.54M | Sell |
36,351
-36,083
| -50% | -$1.53M | 0.06% | 125 |
|
|
2016
Q1 | $4.77M | Sell |
72,434
-36,082
| -33% | -$2.38M | 0.2% | 86 |
|
|
2015
Q4 | $6.75M | Hold |
108,516
| – | – | 0.24% | 77 |
|
|
2015
Q3 | $7.27M | Buy |
108,516
+36,350
| +50% | +$2.43M | 0.26% | 74 |
|
|
2015
Q2 | $7.02M | Hold |
72,166
| – | – | 0.25% | 70 |
|
|
2015
Q1 | $6.75M | Hold |
72,166
| – | – | 0.27% | 67 |
|
|
2014
Q4 | $6.42M | Hold |
72,166
| – | – | 0.3% | 65 |
|
|
2014
Q3 | $4.99M | Hold |
72,166
| – | – | 0.23% | 73 |
|
|
2014
Q2 | $4.14M | Sell |
72,166
-24,055
| -25% | -$1.38M | 0.38% | 49 |
|
|
2014
Q1 | $3.82M | Hold |
96,221
| – | – | 0.38% | 48 |
|
|
2013
Q4 | $4.04M | Sell |
96,221
-32,074
| -25% | -$1.35M | 0.42% | 39 |
|
|
2013
Q3 | $3.84M | Buy |
128,295
+59,966
| +88% | +$1.79M | 0.43% | 48 |
|
|
2013
Q2 | $3.62M | Buy |
+68,329
| New | +$3.62M | 0.49% | 46 |
|